Lung Injury D055370

Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Injury

Diseases [C] » Wounds and Injuries [C26] » Thoracic Injuries » Lung Injury

Description

Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.   MeSH

Subtype Terms (5)

Acute Lung Injury
66 drugs (41 approved, 25 experimental)

Meconium Aspiration Syndrome
7 drugs (2 approved, 5 experimental)

Pneumoconiosis
1 experimental drug

Radiation Pneumonitis
19 drugs (13 approved, 6 experimental)


Phase 2 Indicated Drugs (1)

Phase 1 Indicated Drugs (1)


Organization Involved with Phase 2 Indications (65)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.